Cancer Drug Avastin Increases Risk of Blood Clots When Taken with Chemotherapy
|
Recent research at the Stony Brook University Cancer Center has revealed that Avastin, the cancer drug, increases the risk of blood clots in the veins by some 33% when it is taken together with chemotherapy.
The study was published in The Journal of the American Medical Association and looked at 15 previous clinical trials involving a total of nearly 8,000 persons. It found that Avastin, which is marketed by Roche and Genentech, increased the risk of blood clots from about 10% to about 13%.
Dr Shenhong Wu, leader of the study, said that this is “a significant increased risk with Avastin for patients while they are taking chemotherapy”.
Recent Comments